The Impact of Switching to a Second Antifibrotic Therapy on Outcomes in Patients With IPF in the Empire Registry Treated With Pirfenidone or Nintedanib
Bildiriler > Özet Bildiri
Yazarlar: M.K. Vasakova, Nesrin MOĞULKOÇ BISHOP, M. Kramer, M. Doubková, M. Placková, V. Müller, M.J. Studnicka, M. Zurkova, L. Lacina, K. Lewandowska, V. Bartos, P. Ovesna, J. Gregor
B17. EMERGING DATA ON DISEASE AND SYMPTOM BASED THERAPEUTICS FOR PATIENTS WITH IPF, , , Uluslararası, Özet Bildiri, ss A2779-A2779
DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a2779